A study using a new scan to look at heart disease
Part of Heart & circulation clinical trials.
This trial is testing a new imaging method (68Ga-FAPI PET/CMR) to better see and understand heart problems. It might help doctors diagnose or monitor conditions like heart failure or inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with a heart disease by a heart doctor.
- You need to be over 18 years old.
- Your heart condition should be stable, meaning no recent changes in symptoms or treatment.
- You must be able to give consent and follow study procedures.
- You cannot have cancer or certain metal implants like pacemakers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced imaging (PET scans) to look at how well blood vessels and organs are working, which may help understand heart disease. It is open to people with heart disease and also to healthy volunteers.
This study uses a special PET scan to look for scarring (fibrosis) in the heart muscle of people with heart failure. It may help doctors better understand why some hearts get stiff or weak.
This study uses advanced imaging (PET/MRI) to look at how kidney disease affects the heart and blood vessels. It may help doctors better understand and treat chronic kidney disease.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
This study looks at new ways to detect and predict heart problems in people with Fabry disease. By participating, you may help improve early diagnosis and care for this condition.
This study uses a special PET scan (68Ga-FAPI) to look at inflammation in the heart. It may help researchers understand heart failure and cardiac sarcoidosis better.
Hear when a new Cardiovascular Diseases (CVD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.